Ditchcarbon
  • Contact
  1. Organizations
  2. Genus
Public Profile
Pharmaceutical Preparation Manufacturing
GB
updated 21 days ago

Genus Sustainability Profile

Company website

Genus plc, commonly referred to as Genus, is a leading global player in the biotechnology industry, headquartered in Great Britain. Founded in 1938, the company has established itself as a pioneer in animal genetics, focusing on improving livestock productivity and sustainability. With major operations across North America, Europe, and Asia, Genus is dedicated to advancing agricultural practices through innovative breeding solutions. The company offers a range of core products and services, including genetic improvement programmes for cattle and pigs, which are distinguished by their emphasis on health, efficiency, and environmental sustainability. Genus has achieved notable milestones, such as being the first to introduce genomic selection in livestock, solidifying its market position as a trusted partner for farmers worldwide. With a commitment to research and development, Genus continues to lead the way in enhancing food security and animal welfare.

DitchCarbon Score

How does Genus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

46

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Genus's score of 46 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.

65%

Let us know if this data was useful to you

Genus's reported carbon emissions

In 2024, Genus reported total carbon emissions of approximately 656,297,950 kg CO2e, with significant contributions from Scope 3 emissions at about 649,297,640 kg CO2e. Scope 1 emissions were recorded at about 200,000 kg CO2e, while Scope 2 emissions totalled approximately 6,732,310 kg CO2e. In 2023, the company’s emissions were slightly lower, with total emissions of about 556,679,690 kg CO2e, comprising 321,550 kg CO2e from Scope 1, 5,691,670 kg CO2e from Scope 2, and 542,957,930 kg CO2e from Scope 3. For the UK operations in 2023, Genus reported Scope 1 emissions of approximately 2,923,000 kg CO2e and Scope 2 emissions of about 162,000 kg CO2e, leading to a combined total of around 3,086,000 kg CO2e for Scope 1 and 2. In 2022, UK emissions were about 2,461,000 kg CO2e for Scope 1 and 150,000 kg CO2e for Scope 2, totalling approximately 2,611,000 kg CO2e. Despite the substantial emissions figures, Genus has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or SBTi commitments. The company’s emissions data is not cascaded from a parent organisation, ensuring that the reported figures are solely reflective of Genus's own operations. Overall, Genus's emissions profile highlights the significant impact of Scope 3 emissions, which dominate their total carbon footprint, underscoring the need for comprehensive strategies to address these emissions in future climate commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
67,650,000
00,000,000
00,000,000
00,000,000
000,000
000,000
000,000
Scope 2
8,398,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 3
-
00,000,000
00,000,000
00,000,000
00,000,000
000,000,000
000,000,000

How Carbon Intensive is Genus's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Genus's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Genus's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Genus is in GB, which has a very low grid carbon intensity relative to other regions.

Genus's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Genus has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Genus's Emissions with Industry Peers

Pahc

US
•
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

Elanco

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Alltech

US
•
Research and development services (73)
Updated 2 days ago

Dechra

GB
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Cegelec SAS

FR
•
Electrical machinery and apparatus n.e.c. (31)
Updated about 1 month ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy